What is urease?
Urease is an enzyme that catalyses the breakdown of urea into ammonia (NH₃) and carbon dioxide (CO₂).[1] Urea is naturally present in the human stomach — it enters through the bloodstream and diffuses into gastric secretions. For H. pylori, this ambient urea is a survival resource that most organisms don't know how to exploit.
How H. pylori uses urease to survive — step by step
The enzyme sits on the bacteria's outer surface and inside its cells — ready to act the moment urea becomes available in the surrounding gastric environment.
Urea (CO(NH₂)₂) → 2 NH₃ + CO₂. The ammonia is a base — it immediately begins neutralising the acid around the bacteria.
The ammonia creates a localised zone of significantly higher pH — approximately pH 6–7 — around the bacteria. Inside this zone, H. pylori is effectively shielded from the extreme acid surrounding it.
Protected by its ammonia shield, the bacteria can now migrate toward the stomach wall, attach to epithelial cells using adhesion proteins, and establish a persistent infection.
Without urease, H. pylori would be killed by stomach acid within minutes of entering the stomach. Urease is not merely useful for H. pylori — it is existential. No urease, no H. pylori infection.
How urease is used to detect H. pylori
The same biochemical reaction that keeps H. pylori alive is also what makes it detectable. Both primary diagnostic tests exploit urease activity:
Why targeting urease is a valid therapeutic strategy
If urease is H. pylori's primary survival mechanism, inhibiting urease makes the stomach environment hostile to the bacteria. Without functional urease, H. pylori cannot neutralise the acid around it. Its ability to colonise, persist, and cause damage is significantly reduced.
Multiple peer-reviewed studies have demonstrated that specific flavonoids inhibit H. pylori urease:[2][3]
- Quercetin — demonstrated urease inhibition in multiple in vitro studies
- Myricetin — characterised inhibitory mechanism at the molecular level (Xiao ZP et al., 2007)
- Catechin — inhibits urease and disrupts H. pylori cell membrane integrity
Urease and ammonia: the collateral damage
Urease doesn't just help H. pylori survive. The ammonia it continuously produces is itself directly toxic to the stomach lining.
Ammonia at high localised concentrations damages gastric epithelial cells[1] — the cells that form the stomach wall and produce the protective mucus layer. This is part of the mechanism by which H. pylori progressively erodes the mucosa over months and years.
This is why addressing H. pylori is not only about eliminating the bacteria. The ongoing ammonia damage to mucosal cells requires targeted support — which is what the mucosal-protective properties of licorice-derived flavonoids provide alongside urease inhibition.
Urease is H. pylori's survival engine and its Achilles heel simultaneously. It creates the conditions the bacteria needs to colonise the stomach, leaves behind the ammonia damage that erodes the mucosal lining, and provides the biochemical signature that both detects and most precisely targets the infection.
References
- Mobley HL. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Alimentary Pharmacology & Therapeutics. 1996;10 Suppl 1:57–64. PMID 8730257. The definitive reference establishing urease as H. pylori's primary acid-survival mechanism and its role in gastric pathology including direct ammonia toxicity to epithelial cells.
- Xiao ZP, Shi DS, Li HQ, et al. Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease. Bioorganic & Medicinal Chemistry. 2007;15(11):3703–3710. PMID 17069924. Demonstrates quercetin and myricetin as potent competitive inhibitors of H. pylori urease in vitro, characterising the molecular basis for flavonoid-based urease inhibition.
- Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. International Journal of Antimicrobial Agents. 2005;26(5):343–356. PMID 16323269. Comprehensive review of flavonoid antimicrobial mechanisms including membrane disruption in H. pylori and catechin's established inhibitory activity.
The urease mechanism described is well-established in clinical microbiology: Mobley (1996) defined the structural and functional basis of H. pylori urease. The flavonoid urease inhibition claims are supported by Xiao et al. (2007) for myricetin and quercetin, and Cushnie & Lamb (2005) for catechin. The TumGard India Gut Health Report 2026 adds the epidemiological dimension: in 2,263 endoscopy patients, 62% tested positive for H. pylori — a population in whom the urease mechanism is active and ongoing daily.